Tezepelumab
D5241C00006
Phase 3 mab active
Quick answer
Tezepelumab for Chronic Obstructive Pulmonary Disease (COPD) is a Phase 3 program (mab) at AstraZeneca with 2 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Phase 3
- Modality
- mab
- Status
- active